Bone Graft For Papilon Lefevre Patient
Bone Graft For Papilon Lefevre Patient
Bone Graft For Papilon Lefevre Patient
Papillon-Lefèvre syndrome (PLS) is a rare autosomal recessive disorder of keratinization associated with
palmoplantar keratoderma and severe periodontitis resulting in complete edentulism in late adolescence. The
pathognomonic dental features of PLS are pathologic migration, hypermobility, and exfoliation of the teeth
without any signs of root resorption. It has been suggested that an effective way to treat PLS patients presenting
early in the disease progression is extraction of the erupted primary dentition or hopeless permanent teeth
followed by antibiotic coverage with periodontal therapy for the remaining teeth. Unfortunately, studies have
shown that this regimen only temporarily delays the progression of periodontal disease and does not prevent
further tooth loss and bone destruction in the long term. Post–tooth loss, atrophic ridges make conventional
prosthodontic rehabilitation quite challenging, and more recently, implant-supported prostheses have been
considered as a viable alternative. In a PLS patient, implant placement is complicated by inadequate bone
volume; thus, bone augmentation techniques or the use of short implants is often considered. When large
volumes of bone are required, parietal calvarium bone can be used to predictably reconstruct severe defects. A
PLS patient aged 21 years presented a chief complaint of ill-fitting conventional complete dentures. The patient
had severely atrophic ridges, requiring significant bone augmentation for an implant-supported prosthesis. The
present case is the first example of bone augmentation using autogenous calvarium parietal graft followed
by endosseous implant placement and prosthetic restoration in a PLS patient. Int J Oral Maxillofac Implants
2017;32:e259–e264. doi: 10.11607/jomi.6282
© 2017 BY QUINTESSENCE PUBLISHING CO, INC. PRINTING OF THIS DOCUMENT IS RESTRICTED TO PERSONAL USE ONLY.
NO PART MAY BE REPRODUCED OR TRANSMITTED IN ANY FORM WITHOUT WRITTEN PERMISSION FROM THE PUBLISHER.
Kinaia et al
© 2017 BY QUINTESSENCE PUBLISHING CO, INC. PRINTING OF THIS DOCUMENT IS RESTRICTED TO PERSONAL USE ONLY.
NO PART MAY BE REPRODUCED OR TRANSMITTED IN ANY FORM WITHOUT WRITTEN PERMISSION FROM THE PUBLISHER.
Kinaia et al
a b c
f
Fig 1 Initial patient presentation. (a) Extraoral facial profile front view. (b) Extraoral
facial profile lateral view. (c) Palmoplantar hyperkeratosis on hands. (d) Palmoplantar
hyperkeratosis on feet. (e) Clinical occlusal maxilla. (f) CBCT for maxilla.
a b
c d
© 2017 BY QUINTESSENCE PUBLISHING CO, INC. PRINTING OF THIS DOCUMENT IS RESTRICTED TO PERSONAL USE ONLY.
NO PART MAY BE REPRODUCED OR TRANSMITTED IN ANY FORM WITHOUT WRITTEN PERMISSION FROM THE PUBLISHER.
Kinaia et al
b c d
© 2017 BY QUINTESSENCE PUBLISHING CO, INC. PRINTING OF THIS DOCUMENT IS RESTRICTED TO PERSONAL USE ONLY.
NO PART MAY BE REPRODUCED OR TRANSMITTED IN ANY FORM WITHOUT WRITTEN PERMISSION FROM THE PUBLISHER.
Kinaia et al
b c d
physically. The present patient presented very frus- retain, or stabilize traditional removable prostheses. Au-
trated with the failure of three previous removable togenous bone harvested from the calvarium has been
prostheses and felt unable to function adequately in reported to provide adequate bone volume and contours
his day‑to‑day life. The reasons for severe rapidly pro- to allow for predictable vertical and horizontal bone aug-
gressing periodontitis in PLS patients have not been mentation.17 The use of cranium bone generally results in
fully elucidated; however, the possible mechanisms less morbidity compared with grafts taken from the tibia
have been classified into three domains: immunologic, or iliac crest.16 In a case series by Restoy-Lozano et al, a
microbiologic, and genetic.19 From the immunologic mean vertical bone gain of 5.04 ± 1.69 mm was obtained
perspective, neutrophils have displayed impaired che- in 10 patients.17 Provided that adequate bone volume is
motaxis, phagocytosis, and bactericidal activities.20,21 present or can be achieved, osseointegrated implants
Microbiologically, the presence of A actinomycetem- provide an alternative with major improvements in the
comitans has been noted in periodontal pockets of PLS long-term prognosis for oral rehabilitation.15,24 A grow-
patients, and could be considered as a triggering fac- ing body of evidence continues to suggest that PLS
tor.6,22 This finding has been expanded upon by Clere- patients should be considered candidates for full-arch
hugh et al, who identified a broader range of putative implant-supported prostheses.
periodontopathogens with presence in the oral cav-
ity of PLS-affected individuals, including F nucleatum
and P gingivalis.23 The investigation of genetic factors CONCLUSIONS
has led to the hypothesis that inactivation of the ca-
thepsin-C gene is primarily responsible for abnormali- Although the long-term stability of PLS cases treated
ties in the skin development and periodontal disease with implant-supported prostheses has not been es-
progression in PLS patients.4 This gene is also mutated tablished, the present case demonstrates that despite
in two related conditions: Haim-Munk syndrome and several failed attempts at prosthetic rehabilitation,
aggressive periodontitis. A clinical manifestation com- a potential treatment option for the restoration of a
mon to all of these disorders is early onset, severe, and severely atrophic arch consists of an interdisciplinary
rapidly progressing periodontal destruction. approach to treatment with autogenous calvarium
Implant dentistry has broadened the treatment op- grafts followed by endosseous implant placement and
tions for severely atrophic arches unable to support, implant-supported prosthesis fabrication. Treatment
© 2017 BY QUINTESSENCE PUBLISHING CO, INC. PRINTING OF THIS DOCUMENT IS RESTRICTED TO PERSONAL USE ONLY.
NO PART MAY BE REPRODUCED OR TRANSMITTED IN ANY FORM WITHOUT WRITTEN PERMISSION FROM THE PUBLISHER.
Kinaia et al
planning may appear daunting for cases complicated 8. Rateitschak-Plüss EM, Schroeder HE. History of periodontitis in a
child with Papillon-Lefèvre syndrome. A case report. J Periodontol
by severe arch atrophy secondary to PLS, necessitating 1984;55:35–46.
clear communication and partnership between mem- 9. Tinanoff N, Tanzer JM, Kornman KS, Maderazo EG. Treatment of
bers of the dental team to ensure proper and logical the periodontal component of Papillon-Lefèvre syndrome. J Clin
Periodontol 1986;13:6–10.
treatment progression. This case was managed using 10. Tinanoff N, Tempro P, Maderazo EG. Dental treatment of
an interdisciplinary approach, resulting in a treatment Papillon-Lefèvre syndrome: 15-year follow-up. J Clin Periodontol
outcome that met patient expectations, and led to a 1995;22:609–612.
11. Nickles K, Schacher B, Ratka-Krüger P, Krebs M, Eickholz P. Long-
significant improvement to self-image and confidence term results after treatment of periodontitis in patients with
in social settings. Papillon-Lefèvre syndrome: Success and failure. J Clin Periodontol
2013;40:789–798.
12. Al Farraj AlDosari A. Oral rehabilitation of a case of Papillon-Lefe-
vre syndrome with dental implants. Saudi Med J 2013;34:424–427.
ACKNOWLEDGMENTS 13. Woo I, Brunner DP, Yamashita DD, Le BT. Dental implants in a
young patient with Papillon-Lefevre syndrome: A case report.
The authors declare no conflicts of interest. No author received Implant Dent 2003;12:140–144.
14. Senel FC, Altintas NY, Bagis B, et al. A 3-year follow-up of the reha-
monetary compensation for this manuscript.
bilitation of Papillon-Lefèvre syndrome by dental implants. J Oral
Maxillofac Surg 2012;70:163–167.
15. Ahmadian L, Monzavi A, Arbabi R, Hashemi HM. Full-mouth rehabili-
tation of an edentulous patient with Papillon-Lefèvre syndrome using
REFERENCES dental implants: A clinical report. J Prosthodont 2011;20:643–648.
16. Tessier P. Autogenous bone grafts taken from the calvarium for
1. Ullbro C, Crossner CG, Nederfors T, Alfadley A, Thestrup-Pedersen facial and cranial applications. Clin Plast Surg 1982;9:531–538.
K. Dermatologic and oral findings in a cohort of 47 patients with 17. Restoy-Lozano A, Dominguez-Mompell JL, Infante-Cossio P, Lara-
Papillon-Lefèvre syndrome. J Am Acad Dermatol 2003;48:345–351. Chao J, Lopez-Pizarro V. Calvarial bone grafting for three-dimen-
2. Wani AA, Devkar N, Patole MS, Shouche YS. Description of two sional reconstruction of severe maxillary defects: A case series. Int
new cathepsin C gene mutations in patients with Papillon-Lefèvre J Oral Maxillofac Implants 2015;30:880–890.
syndrome. J Periodontol 2006;77:233–237. 18. Tulasne J. Harvesting the parietal bone [in French]. Rev Stomatol
3. Shah AF, Tangade P, Agarwal S. Papillon-Lefevre syndrome: Report- Chir Maxillofac 2003;104:159–161.
ing consanguinity as a risk factor. Saudi Dent J 2014;26:126–131. 19. Hattab FN, Rawashdeh MA, Yassin OM, al-Momani AS, al-Ubosi
4. Hart TC, Hart PS, Bowden DW, et al. Mutations of the cathepsin C MM. Papillon-Lefèvre syndrome: A review of the literature and
gene are responsible for Papillon-Lefèvre syndrome. J Med Genet report of 4 cases. J Periodontol 1995;66:413–420.
1999;36:881–887. 20. Liu R, Cao C, Meng H, Tang Z. Leukocyte functions in 2 cases of
5. Toomes C, James J, Wood AJ, et al. Loss-of-function mutations in Papillon-Lefèvre syndrome. J Clin Periodontol 2000;27:69–73.
the cathepsin C gene result in periodontal disease and palmoplan- 21. Lundgren T, Parhar RS, Renvert S, Tatakis DN. Impaired cytotoxicity
tar keratosis. Nat Genet 1999;23:421–424. in Papillon-Lefèvre syndrome. J Dent Res 2005;84:414–417.
6. Newman M, Angel I, Karge H, Weiner M, Grinenko V, Schusterman 22. González JR, Chabrier L, Rodriguez RJ. Papillon-Lefevre syndrome: A
L. Bacterial studies of the Papillon-Lefèvre syndrome. J Dent Res case report and review of the literature. P R Health Sci J 1997;16:279–281.
1977;56:545. 23. Clerehugh V, Drucker DB, Seymour GJ, Bird PS. Microbiological
7. Pilger U, Hennies HC, Truschnegg A, Aberer E. Late-onset Papillon- and serological investigations of oral lesions in Papillon-Lefèvre
Lefèvre syndrome without alteration of the cathepsin C gene. J Am syndrome. J Clin Pathol 1996;49:255–257.
Acad Dermatol 2003;49(suppl):s240–s243. 24. Adell R, Lekholm U, Rockler B, Brånemark PI. A 15-year study of
osseointegrated implants in the treatment of the edentulous arch.
Int J Oral Surg 1981;10:387–416.
© 2017 BY QUINTESSENCE PUBLISHING CO, INC. PRINTING OF THIS DOCUMENT IS RESTRICTED TO PERSONAL USE ONLY.
NO PART MAY BE REPRODUCED OR TRANSMITTED IN ANY FORM WITHOUT WRITTEN PERMISSION FROM THE PUBLISHER.